The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think that if you look at the Lancet study that they're basing this on it's a reasonable move to pause hydroxychloroquine it was a over ninety six thousand patients and those patients that were given contracts at chloroquine certainly had an increased incidence of cardiac arrhythmias and a worse outcome than those who didn't get it
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.